BY PATIENCE IVIE IHEJIRIKA, Abuja, SOLA OJO, Kaduna, NICHOLAS DEKERA, Sokoto, Francis Okoye, Maiduguri
Northern Nigeria continues to account for a significant proportion of Nigeria’s tuberculosis burden with Sokoto, Kaduna, Kano, Nasarawa and Kebbi recording some of the country’s highest TB case notification rates as of 2023, even as states in the region are currently battling the disease amid funding cuts.
According to the National Tuberculosis, Leprosy and Buruli Ulcer Control Programme (NTBLCP), Sokoto recorded 537 notified cases per 100,000 population, followed by Kaduna with 332, Kano with 244, Nasarawa with 242 and Kebbi with 240.
The NTBLCP report also revealed that Jigawa recorded the highest percentage increase in TB notifications nationally between 2022 and 2023, at 71 per cent.
The region accounted for nearly 58 per cent of the tuberculosis (TB) cases reported across the country in 2022, with the North-West recording the highest number of infections among the six geopolitical zones.
Data from the federal government’s National Strategic Plan for Tuberculosis Control 2021–2025 showed that the North-West recorded 105,830 TB cases in 2022, while the North-Central and North-East recorded 31,521 and 27,340 cases respectively.
The figures indicate that the three northern geopolitical zones collectively accounted for 164,691 of the 285,561 TB cases notified nationwide in 2022, representing approximately 57.7 per cent of the national total.
The North-West alone accounted for more than one-third of all reported cases, with its notifications increasing from 72,882 in 2021 to 105,830 in 2022.
The North-Central also recorded an increase from 24,177 cases in 2021 to 31,521 in 2022, while notifications in the North-East rose from 22,532 to 27,340 within the same period.
The rising notifications underscore the scale of the disease burden in the region and the importance of strengthening early diagnosis, community screening and access to treatment, particularly among underserved populations.
The Federal Ministry of Health and Social Welfare’s 2023 Annual Report on Tuberculosis, Leprosy and Buruli Ulcer Control Programme disclosed that Nigeria recorded 371,019 TB cases in 2023, the highest annual notification since the establishment of the national programme in 1989.
The report also documented a treatment success rate of 93 per cent among patients registered for treatment in 2023.
Also, figures from the World Health Organisation (WHO) show that Nigeria notified 458,534 TB cases in 2025, indicating continued improvement in case detection nationwide.
According to WHO, children aged zero to 14 years accounted for 46,952 of the notified cases, representing 10 per cent of the total, while 57 per cent of all notified patients were male and 43 per cent female.
Despite improvements in detection, WHO estimates that approximately 63,000 TB cases remain undetected annually in Nigeria, sustaining the risk of continued transmission.
The organisation has identified stigma, limited access to diagnostic services in underserved communities, drug-resistant tuberculosis and TB-HIV co-infection among the challenges confronting the country’s response.
WHO has also reported that about 71 per cent of TB patients and their households face catastrophic costs associated with the disease, largely due to lost income and out-of-pocket expenditure.
The global health agency has therefore called for increased domestic investment, expanded community-based screening and improved access to diagnostic services and treatment to close existing gaps in Nigeria’s tuberculosis response.
In the face of treatment problems occasioned by cuts in the funding, centres in Kaduna State have adopted an inter-facility drug-sharing arrangement to prevent treatment disruptions when some health facilities temporarily run out of medication.
Despite the prevalence in the region, states have faced cuts in funding treatment of the disease, leading to disruption in treatment among patients. But reports say the disruption is being handled as treatment has resumed for patients who return for treatment.
The desk officer in charge of the disease at the Kaduna State Ministry of Health, Dr Sani Aminu, explained that the state’s decentralised treatment arrangement which makes TB services available across primary and secondary healthcare facilities rather than concentrating them in one centre, had strengthened case mapping and response.
Although Aminu was unavailable for further clarification as of the time of filing this report, findings from the facilities visited corroborated his position.
Some facility in-charges who spoke anonymously because they were not authorised to speak to journalists, disclosed that there is distribution of TB drugs following a formal complaint to the relevant authorities.
“Recently, they brought cartons of drugs to us after we made a formal complaint.
“We are giving the drugs free for those who tested positive.
“Presently, the work is ongoing and going very well. So we have enough drugs,” one of the officials said.
Another said, “Despite running out of stock for three consecutive months, the facility managed to sustain treatment by sourcing medication from neighbouring centres.
“In August, September and October, we ran out of stock. But the good thing is we always go to sister facilities to get the drugs,” the official added.
On the welfare of frontline workers, the facility in-charges said government employees had no challenges with salary payments but identified shortages of basic consumables, including hand gloves and protective equipment such as nose masks.
“As government workers, we don’t have issues with salary payment. The only challenge is sourcing consumables like hand gloves and protective gear like nose masks.
“Apart from that, the work is going well,” the official said.
The official further disclosed that patients were regularly attending treatment sessions, with many demonstrating commitment to completing their medication.
“The majority of our patients do come around by Monday. They are taking their drugs very well. The majority are coming, and we have a lot of them who have been treated for six months,” the official said.
The facility also had children aged six, eight and nine receiving TB treatment, although no cases involving pregnant women were recorded at the centre at the time of the visit.
READ ALSO:
- 2027: Northern Elders Decry Rising Political Intolerance, Violence
- 31 APC States’ Youth, Sports Commissioners Targets 8.9m Votes For Tinubu
- ASUP Strike Hits Polytechnics In Four South-West States Over Unpaid Allowances
The officials maintained that the availability of alternative sources of medication within the state’s healthcare network had helped prevent patients from running out of drugs.
“So, in Kaduna, no panic for the tuberculosis drugs because facilities can always get them from sister facilities if at all they temporarily run out of stock,” the official added.
Patients Return For Treatment In Sokoto After Drug Stock-Out
The patients, interviewed at the hospital’s TB treatment centre, said they were forced to discontinue treatment when drugs were not available, but had since resumed after being re-introduced to the free treatment programme.
They commended the government for the free drug support, saying their health had improved significantly, even as they continued to battle stigma in their communities.
“I stopped because there were no drugs. Later, I was introduced to this free medication and I have now continued,” she said.
She said she was now doing well and had been taking her drugs regularly since returning to the centre.
Another patient, Veronica Suleman, also narrated a similar experience, saying the interruption in drug supply nearly derailed her recovery. She has since resumed treatment and is responding well.
Mahmud, another patient at the centre, said he was now stable and grateful for the support, adding that the free drugs removed the financial burden that had made it difficult for him to continue.
All the patients interviewed spoke positively about the care they are now receiving and commended the government for sustaining the free TB treatment programme.
Despite their improved health, the patients said stigma remained a major challenge in their immediate communities.
They said some neighbours and family members still keep their distance because of fear and misinformation about TB.
Aisha said the stigma sometimes makes patients hide their status and avoid coming to the centre, a situation health workers say can lead to treatment interruption and further spread of the disease.
Health experts say stigma remains one of the biggest barriers to TB control in northern Nigeria, alongside drug stock-outs and poor funding.
Frontline workers at the centre said sustained funding is critical to prevent a repeat of the drug run-out that forced patients like Aisha and others to stop treatment.
They called for timely supply of drugs, payment of workers’ allowances and stronger support for TB centres to ensure patients do not abandon treatment again.
Stakeholders also raised concern about whether northern states are budgeting adequately for TB, warning that over-dependence on donor support leaves the programme vulnerable when funding dries up.
They urged state governments to create dedicated TB budget lines, ensure timely release of funds, and sustain free diagnosis and treatment to protect children, pregnant women and other vulnerable groups.
“If drugs are available, patients will come. If drugs run out, they will stop,” a health worker said. “The government must not allow stock-out again.”
Funding Cuts Raise Concern Over Drug Access In Borno
Health workers in Borno State have raised concerns over the possible impact of cuts in tuberculosis funding on patients’ access to essential medicines, warning that any disruption in drug supply could undermine treatment and efforts to control the disease.
The health workers said uninterrupted availability of drugs was critical to ensuring that patients complete their treatment, particularly those who travel long distances to designated treatment centres to collect their medicines.
A health official at the State Specialist Hospital, Abubakar Sani, said TB patients access medicines through designated treatment centres, where diagnosed patients are enrolled, placed on prescribed drugs and monitored throughout their treatment.
Sani stressed the need for continuous drug availability, warning that interruptions could force patients to stop treatment and undermine efforts to prevent the spread of the disease.
Another health worker, Musa Abdullah, said frontline workers were particularly concerned about patients who travel long distances to obtain their medication, noting that drug shortages could place additional pressure on already vulnerable patients.
He said although there was currently no TB patient on admission at the hospital, sustained availability of medicines, laboratory services and proper patient monitoring remained essential for successful treatment.
However, the Borno State Director of Public Health, Dr Goni Imam, said the government had begun measures to ensure uninterrupted treatment and availability of TB drugs and other essential commodities in the state.
Imam said the current Global Fund grant cycle would end in December 2026, with a new three-year cycle expected to commence thereafter, adding that the TB programme had been adequately planned to cushion the impact of the anticipated funding reduction.
He said the state government would be required to assume greater responsibility for financing TB drugs and other commodities under the new funding arrangement.
“The next grant has a funding cut of almost 30 per cent. But the TB programme is well planned and well programmed, so we have planned against the next grant on how to cover this 30 per cent gap,” Imam said.
He listed TB screening and treatment facilities in the state to include the University of Maiduguri Teaching Hospital, State Specialist Hospital, Umaru Shuaibu Ultramodern Hospital, Chest Clinic, Maryam Abacha Women and Children Hospital and Ben Medical Laboratory Ltd, among others.
Imam said strengthening the state’s capacity to sustain TB services would be crucial to ensuring that the funding reduction does not translate into interrupted treatment for patients.
